Notas de prensa

Varian and Google Cloud Collaborate to Aid in the Fight Against Cancer

Varian (NYSE: VAR) today announced it is collaborating with Google Cloud to build an advanced artificial intelligence (AI) based diagnostic platform to aid in the fight against cancer. Varian and...

Varian Medical Systems Invests in Bend It Technologies, Ltd., a Company Developing Novel Steerable Microcatheters

Varian (NYSE: VAR) today announced a new investment in Bend It Technologies Ltd., a medical device company based in Petach Tikva, Israel, that is developing the Bendit® steerable microcatheters...

Varian Announces CEO Succession Plan

Varian (NYSE: VAR) today announced that Chief Executive Officer Dow Wilson, after more than 16 years with the Company, will retire upon the successful completion of the proposed combination of...

CTSI Oncology Solutions, a Varian Company, to Provide Technology-Enabled Services for Radiation Oncology at CHRISTUS Health

CTSI Oncology Solutions, a Varian (NYSE: VAR) company that provides oncology services for healthcare providers worldwide, has entered into a long-term, multi-year agreement with CHRISTUS Health, a...

Varian Becomes First Medical Technology Company Joining the Cancer Drug Development Forum

Varian (NYSE: VAR) announced it has joined the Cancer Drug Development Forum (CDDF) as an industry partner. This makes Varian the first medical technology company to join CDDF, the leading...

Varian Installs World's First ProBeam® 360° Proton Therapy System at Penn Medicine Lancaster General Health

Varian (NYSE: VAR) has started the installation of the cyclotron and gantry for its ProBeam® 360° single-room proton therapy system at Penn Medicine Lancaster General Health's Ann B. Barshinger...

Varian Reports Results for First Quarter of Fiscal Year 2021

First Quarter 2021 Summary Oncology Systems gross orders grew 2% in dollars or 1% in constant currency in the quarter; trailing twelve months gross orders down 5% in dollars or 6% in constant currency

Varian Ranked Highest in Survey of US Radiation Oncology Professionals

Varian (NYSE: VAR) has been recognized again as the leader in the annual IMV ServiceTrak™ Radiation Oncology Systems report, ranking first in all nine of the tracked categories. Additionally,...

Varian Announces First Quarter Fiscal Year 2021 Earnings Release Date

Varian (NYSE: VAR) today announced its first quarter fiscal year 2021 earnings release date. The Company will report results for the first quarter of fiscal year 2021 after market close on...

Varian and the Cincinnati Children's/UC Health Proton Therapy Center Announce Initial Patient Treated in the FAST-01 First Human Clinical Trial of FLASH Therapy for Cancer

Varian (NYSE: VAR) and the Cincinnati Children's/UC Health Proton Therapy Center today announce the start of the first clinical trial of FLASH therapy as part of the recently opened FAST-01 study...